Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 1
2013 2
2015 1
2016 1
2018 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
Rosenblum D, Gutkin A, Kedmi R, Ramishetti S, Veiga N, Jacobi AM, Schubert MS, Friedmann-Morvinski D, Cohen ZR, Behlke MA, Lieberman J, Peer D. Rosenblum D, et al. Among authors: kedmi r. Sci Adv. 2020 Nov 18;6(47):eabc9450. doi: 10.1126/sciadv.abc9450. Print 2020 Nov. Sci Adv. 2020. PMID: 33208369 Free PMC article.
A modular platform for targeted RNAi therapeutics.
Kedmi R, Veiga N, Ramishetti S, Goldsmith M, Rosenblum D, Dammes N, Hazan-Halevy I, Nahary L, Leviatan-Ben-Arye S, Harlev M, Behlke M, Benhar I, Lieberman J, Peer D. Kedmi R, et al. Nat Nanotechnol. 2018 Mar;13(3):214-219. doi: 10.1038/s41565-017-0043-5. Epub 2018 Jan 29. Nat Nanotechnol. 2018. PMID: 29379205
Zooming in on selectins in cancer.
Kedmi R, Peer D. Kedmi R, et al. Sci Transl Med. 2016 Jun 29;8(345):345fs11. doi: 10.1126/scitranslmed.aag1802. Sci Transl Med. 2016. PMID: 27358495 Review.
Integrin-targeted nanoparticles for siRNA delivery.
Ben-Arie N, Kedmi R, Peer D. Ben-Arie N, et al. Among authors: kedmi r. Methods Mol Biol. 2012;757:497-507. doi: 10.1007/978-1-61779-166-6_29. Methods Mol Biol. 2012. PMID: 21909930